Psoriatic Arthritis
The MD Magazine Psoriatic Arthritis condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Female Psoriasis Patients Susceptible to Increased Risk of Depression
A recent study published in the British Journal of Dermatology reported a spike in the risk of depression among women afflicted with psoriasis.
Study shows that adalimumab led to sustained clinical and functional responses in nearly one-third of treatment-refractory patients who completed 10 years of treatment. Patients with shorter disease duration achieved better outcomes, highlighting the need for early treatment.
A recent review looked at the immunopathogenesis of psoriasis, identified key mediators of psoriatic plaques that are being targeted by new and emerging biologic therapies, and highlighted the latest efficacy and safety data from trials of these new agents.
Analysis of a population-based cohort indicates that patients with psoriasis and psoriatic arthritis face an elevated risk of developing heart arrhythmias such as atrial fibrillation.
A review and meta-analysis of a dozen studies indicates that more than 10% of all psoriasis patients have undiagnosed cases of psoriatic arthritis.
Treatment with anti-TNF drugs and DMARDs is associated with clinically significant improvement measures of work disability such as presenteeism and productivity loss in patients with psoriatic arthritis.
Inflammatory chronic diseases such as rheumatoid arthritis, ankylosing spondylitis, and psoriasis bring many treatment challenges. Among them is the fact that biologic therapies for these diseases—particularly anti-TNF agents—while effective, can themselves bring reactivation of a latent tuberculosis infection.

Most Popular

$vacMongoViewPlus$ $vAR$